Americans Will Have Access to Yellow Fever Vaccines

In COVID-19, Latest News by Precision Vaccinations

To meet the yellow fever vaccination needs, the Stamaril vaccine will continue to be available in the USA into mid-2021.
As announced by Sanofi Pasteur in France on December 23, 2020, the U.S. FDA has agreed to authorize the distribution of Stamaril through an Expanded Access Program (EAP) during the YF-VAX vaccine shortage. This EAP is forecast to be effective through mid-2021.

Read More